Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative ulinastatin for prevention of postoperative pancreatic fistula in pancreatic cancer surgery
ChiCTR-IPR-15006940Phase 4Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of ulinastatin in pancreatic cancer (PC) (3 arms), sponsored by Shanghai General Hospital. Primary endpoints: amylase, interleukin-2 and 4 more. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
ulinastatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on ChiCTR-IPR-15006940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006940.